479
Views
3
CrossRef citations to date
0
Altmetric
Drug Profile

Can a fixed-ratio combination of insulin degludec and liraglutide help Type 2 diabetes patients to optimize glycemic control across the day?

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Suhaj Abdulsalim, Munawar Peringadi Vayalil & Sonal Sekhar Miraj. (2016) New fixed dose chemical combinations: the way forward for better diabetes type II management?. Expert Opinion on Pharmacotherapy 17:16, pages 2207-2214.
Read now

Articles from other publishers (2)

Jianping Zhai, Li Li, Lihou Dong, Kelly Dong, Shensi Xiang, Luolan Gui, Jiaying Zhang, Haifeng Song & Zhiqiang Ge. (2020) Simultaneous quantitative determination of liraglutide and insulin degludec in rat plasma by liquid chromatography–tandem mass spectrometry method and its application. Biomedical Chromatography 34:10.
Crossref
Sultan Linjawi, Bruce W. Bode, Louis B. Chaykin, Jean-Pierre Courrèges, Yehuda Handelsman, Lucine M. Lehmann, Abhishek Mishra & Richard W. Simpson. (2016) The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial. Diabetes Therapy 8:1, pages 101-114.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.